Physician profile
Dominik Fleifel
NPI 1003436676
$7,363.46
in general payments reported to CMS, 2019-2025
7 companies · $7,363 in 2025
The $7,363 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $7,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,750 · Travel and Lodging: $1,778 · Food and Beverage: $1,655 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,750.00 |
| Travel and Lodging | $1,777.96 |
| Food and Beverage | $1,654.85 |
| Education | $180.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,750.00 | 2025 | |
| Stryker Corporation | $2,947.17 | 2025 | Mako, Triathlon, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $291.89 | 2025 | Persona |
| Depuy Synthes Sales INC. | $170.83 | 2025 | Na, Tfn-Advance |
| Kerecis Limited | $96.95 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Avita Medical Americas, LLC | $83.99 | 2025 | Permeaderm, Cohealyx, Recell |
| Medical Device Business Services, INC. | $22.63 | 2025 | Actis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominik Fleifel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.